Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this?
Related Articles
Impact Factor
For localised prostate cancer, does technology equal progress?
News
PSA for prostate cancer screening: still a balancing act
Senza categoria